Home / Inspections / 1061410

FDA Inspection 1061410 — RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank

RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank — FEI 2270850

The FDA completed an inspection of RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank on July 26, 2018 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, NJ (United States)

Facility

Other inspections at this facility

  • 1314854 (NAI Wed Apr 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1220208 (VAI Fri Oct 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1168186 (NAI Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 989086 (NAI Thu Sep 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 887560 (NAI Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources